Both in Pharmaceuticals
Amphastar Pharmaceuticals vs Maravai LifeSciences Holdings
Over the past year AMPH returned −0.9% and MRVI returned +170.3%; their daily moves had a correlation of 0.01.
AMPH −0.9% MRVI +170.3%Growth of $1, one year, split-adjusted
| Metric | AMPH | MRVI |
|---|---|---|
| Price | $26.68 | $7.65 |
| Market cap | $1.13B | $1.14B |
| Today | −2.59% | +0.26% |
| 1 month | +21.2% | −0.4% |
| 6 months | +38.8% | +165.6% |
| Year to date | −0.4% | +135.4% |
| 1 year | −0.6% | +171.3% |
| Revenue growth (YoY) | +5.4% | +8.5% |
| Gross margin | 50.8% | 40.1% |
| Net margin | 16.5% | −24.1% |
| P/E (TTM) | 14.4× | — |
| Price / sales | 1.6× | 5.5× |
| Net cash | -$321.9M | -$106.6M |
| Dividend yield | — | — |
| Volatility (60d) | 35.4% | 73.2% |
| Short % of float | 17.1% | 9.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).